Gene · 5350
Papers4,369
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 4,369
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Altering Calcium Sensitivity in Heart Failure: A Crossroads of Disease Etiology and Therapeutic Innovation. | Int J Mol Sci | 2023 | 38139404 | PubTator, text mining | PubMed |
| Cardiac Magnetic Resonance as Risk Stratification Tool in Non-Ischemic Dilated Cardiomyopathy Referred for Implantable Cardioverter Defibrillator Therapy-State of Art and Perspectives. | J Clin Med | 2023 | 38137821 | PubTator, text mining | PubMed |
| Management Strategies in Arrhythmogenic Cardiomyopathy across the Spectrum of Ventricular Involvement. | Biomedicines | 2023 | 38137480 | PubTator, text mining | PubMed |
| Novel pathogenic variant in MED12 causing non-syndromic dilated cardiomyopathy. | BMC Med Genomics | 2023 | 38129817 | PubTator, text mining | PubMed |
| O-GlcNAcylation: cellular physiology and therapeutic target for human diseases. | MedComm (2020) | 2023 | 38116061 | PubTator, text mining | PubMed |
| Single-cell transcriptional landscape of long non-coding RNAs orchestrating mouse heart development. | Cell Death Dis | 2023 | 38110334 | PubTator, text mining | PubMed |
| Comprehensive review on gene mutations contributing to dilated cardiomyopathy. | Front Cardiovasc Med | 2023 | 38107262 | PubTator, text mining | PubMed |
| Cardiac optogenetics: shining light on signaling pathways. | Pflugers Arch | 2023 | 38097805 | PubTator, text mining | PubMed |
| Case Report: Mutation in TNNI3(c. 544G>A): a novel likely pathogenic mechanism of neonatal dilated cardiomyopathy. | Front Pediatr | 2023 | 38089682 | PubTator, text mining | PubMed |
Hypertrophic cardiomyopathy is characterized by alterations of the mitochondrial calcium uniporter complex proteins: insights from patients with aortic valve stenosis versus hypertrophic obstructive cardiomyopathy. | Front Pharmacol | 2023 | 38074139 | PubTator, text mining | PubMed |
| A comprehensive review of the novel therapeutic targets for the treatment of diabetic cardiomyopathy. | Ther Adv Cardiovasc Dis | 2023 | 38069578 | PubTator, text mining | PubMed |
| PDE4 Phosphodiesterases in Cardiovascular Diseases: Key Pathophysiological Players and Potential Therapeutic Targets. | Int J Mol Sci | 2023 | 38069339 | PubTator, text mining | PubMed |
| How Imaging Techniques Improve Ventricular Arrhythmia Ablation: A Multimodality-Based Approach. | J Clin Med | 2023 | 38068472 | PubTator, text mining | PubMed |
| Challenges and Applications of Genetic Testing in Dilated Cardiomyopathy: Genotype, Phenotype and Clinical Implications. | Arq Bras Cardiol | 2023 | 38055534 | PubTator, text mining | PubMed |
| FRESH™ 3D bioprinted cardiac tissue, a bioengineered platform for in vitro pharmacology. | APL Bioeng | 2023 | 38046544 | PubTator, text mining | PubMed |
| Selective activation of intracellular β1AR using a spatially restricted antagonist. | bioRxiv | 2023 | 38045405 | PubTator, text mining | PubMed |
| Aortic aneurysms: current pathogenesis and therapeutic targets. | Exp Mol Med | 2023 | 38036736 | PubTator, text mining | PubMed |
| Efficacy of exon-skipping therapy for DMD cardiomyopathy with mutations in actin binding domain 1. | Mol Ther Nucleic Acids | 2023 | 38028197 | PubTator, text mining | PubMed |
| Recent Advances in Inherited Cardiac Arrhythmias and Their Genetic Testing. | Cureus | 2023 | 38021622 | PubTator, text mining | PubMed |
| Utilities and Limitations of Cardiac Magnetic Resonance Imaging in Dilated Cardiomyopathy. | Korean J Radiol | 2023 | 38016680 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5350/papers?page=13